Psychosis

The Myth of Schizophrenia as a Progressive Brain Disease

Schizophrenia has historically been considered to be a deteriorating disease, a view reinforced by recent MRI findings of progressive brain tissue loss over the early years of illness. Zipursky and colleagues challenge this concept. Schizophrenia Bulletin [More…]

Read More
DETAIL

Sixth Annual Chair Summit Begins This Week

This week a Master Class for Neuroscience Development called the Chair Summit takes place in Tampa, FL (Sept 26-28, 2013). In the early days of medical training in Kos, students, trainees and medical colleagues would gather to discuss their cases and the latest science with Hippocrates.  This model of education was maintained throughout the centuries […]

Read More
DETAIL

Essential Components of First-Episode Psychosis Services

A study published in May 1st, 2013 Psychiatric Services identified essential evidence-based components of first-episode psychosis services. The research took place in two stages. First a systematic literature review, then, a consensus-building technique, the Delphi, was used with an international panel of experts. The panelists were presented the evidence-based components identified in the review, together […]

Read More
DETAIL

The Nature of Relapse in Schizophrenia

Discontinuation of treatment in schizophrenia results in very high relapse rates, even after a single psychotic episode. A new review in BMC Psychiatry asserts that multiple relapses characterze the course of illness in most patients with schizophrenia, yet the nature of these episodes has not been extensively researched and clinicians may not always be aware […]

Read More
DETAIL

Non-adherence to Antipsychotics and Cardiometabolic Medication Result in Health Care Utilization and Costs

A new study in Psychiatric Services examined the association between adherence to antipsychotic and cardiometabolic medication and the use of health care services and expenditures. A total of 87,015 unique patients with schizophrenia who received at least one antipsychotic medication were reviewed via Medicaid files from 2004 to 2008. An annual cross-sections of patients with […]

Read More
DETAIL

Early Detection and Intervention in Psychosis Improves 10-Year Outcome

Early detection in first-episode psychosis confers advantages for negative, cognitive, and depressive symptoms after 1, 2, and 5 years, but longitudinal effects have been unknown. A new article  published in the American Journal of Psychiatry investigated the differences in symptoms and recovery after 10 years between regional health care sectors with and without a comprehensive […]

Read More
DETAIL

Chair Summit Meeting Highlights – available now in HORM

Article series from the 3rd Annual Chair Summit, The Master Class for Neuroscience Professional Development (Chair Summit) available now in Health Outcomes Research in Medicine journal (HORM) The continuing professional development of clinicians protects one of our nation’s most precious human resources—a well-trained force of health care workers. Making decisions to manage illness and handle […]

Read More
DETAIL

Persistent negative symptoms in first-episode schizophrenia

A study published in Schizophrenia Research describes that negative symptoms, which are a core feature of schizophrenia, are generally understudied. Researchers evaluated the prevalence and stability of primary negative symptoms, and factors associated with persistent primary negative symptoms in a first-episode sample. Individuals (N=93) aged 18 to 55years presenting with first-episode schizophrenia-spectrum disorder were studied. […]

Read More
DETAIL